Biodexa Pharmaceuticals (BDRX) Interest Coverage Ratio (2013 - 2025)

Biodexa Pharmaceuticals has disclosed Interest Coverage Ratio across 13 years of filings, most recently posting 29.75 for Q2 2025.

• In Q2 2025, Interest Coverage Ratio changed N/A year-over-year to 29.75; the TTM figure through Jun 2025 stood at 81.0 (changed N/A YoY), while the FY2025 annual figure was 37.75, down 32.29% from the prior year.
• Interest Coverage Ratio came in at 29.75 for Q2 2025 at Biodexa Pharmaceuticals, down from 86.18 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 195.46 in Q4 2023 to a low of 20.73 in Q3 2021.
• Average Interest Coverage Ratio over 5 years is 111.98, with a median of 121.8 recorded in 2024.
• Year-over-year, Interest Coverage Ratio tumbled 97.51% in 2021 and soared 659.34% in 2022.
• Over 5 years, Interest Coverage Ratio stood at 44.86 in 2021, then jumped by 275.68% to 168.53 in 2022, then increased by 15.98% to 195.46 in 2023, then plunged by 55.91% to 86.18 in 2024, then plunged by 65.48% to 29.75 in 2025.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 29.75 in Q2 2025, 86.18 in Q4 2024, and 195.46 in Q4 2023.